Adding a wealth of global expertise in real-world data, market access, and business strategy to enhance the company’s indication-discovery mission. She has been pivotal in refining chAIron’s analytic frameworks and strengthening go‑to‑market positioning, ensuring faster, smarter molecule-to-indication mapping across the globe.

With leadership experience at various companies in Life Sciences—plus a rich scientific foundation from her PhD in microbiology—Ana excels at integrating rich patient-data, AI, and stakeholder engagement. Her guidance empowers chAIron to demonstrate clear commercial value to partners and investors.